Antiarrhythmic effect of reverse electrical remodeling associated with cardiac resynchronization therapy

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 3, 2011, Pages 357-364

  Tereshchenko, Larisa G ^a,b   Henrikson, Charles A ^a   Stempniewicz, Peter ^a   Han, Lichy ^a   Berger, Ronald D ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cardiac resynchronization therapy; electrical remodeling; heart failure; ventricular tachyarrhythmia

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART BUNDLE BRANCH BLOCK; HEART EJECTION FRACTION; HEART FAILURE; HEART VENTRICLE REMODELING; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; QRS COMPLEX; REVERSE ELECTRICAL REMODELING;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; MALE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 79952477573     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2010.02974.x     Document Type: Article

References (43)

1. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De MT, Carson P, et al,. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
2. Anand IS, Carson P, Galle E, Song R, Boehmer J, Ghali JK, Jaski B, et al,. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: Results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial. Circulation 2009; 119: 969-977.
3. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA, III, et al,. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-1338.
4. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L,. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549. (Pubitemid 40517094)
5. Nelson GS, Berger RD, Fetics BJ, Talbot M, Spinelli JC, Hare JM, Kass DA,. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000; 102: 3053-3059.
6. Abraham WT, Fisher WG, Smith AL, DeLurgio DB, Leon AR, Loh E, Kocovic DZ, et al,. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853. (Pubitemid 34603028)
7. Hamdan MH, Zagrodzky JD, Joglar JA, Sheehan CJ, Ramaswamy K, Erdner JF, Page RL, et al,. Biventricular pacing decreases sympathetic activity compared with right ventricular pacing in patients with depressed ejection fraction. Circulation 2000; 102: 1027-1032. (Pubitemid 30656010)
8. Higgins SL, Hummel JD, Niazi IK, Giudici MC, Worley SJ, Saxon LA, Boehmer JP, et al,. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003; 42: 1454-1459. (Pubitemid 37267289)
9. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, et al,. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: The MIRACLE ICD Trial. JAMA 2003; 289: 2685-2694. (Pubitemid 37430139)
10. Wilkoff BL, Hess M, Young J, Abraham WT,. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol 2004; 15: 1002-1009. (Pubitemid 39281528)
11. Guerra JM, Wu J, Miller JM, Groh WJ,. Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade. J Cardiovasc Electrophysiol 2003; 14: 1245-1247. (Pubitemid 37455415)
12. Di CA, Bongiorni MG, Arena G, Soldati E, Giannola G, Zucchelli G, Balbarini A,. New-onset ventricular tachycardia after cardiac resynchronization therapy. J Interv Card Electrophysiol 2005; 12: 231-235. (Pubitemid 41201699)
13. Turitto G, Haq S, Benson D, El-Sherif N,. Torsade de pointes: An electrophysiological effect of cardiac resynchronization? Pacing Clin Electrophysiol 2006; 29: 520-522.
14. Carson P, Anand I, OConnor C, Jaski B, Steinberg J, Lwin A, Lindenfeld J, et al,. Mode of death in advanced heart failure: The Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. J Am Coll Cardiol 2005; 46: 2329-2334. (Pubitemid 41785506)
15. Higgins SL, Yong P, Sheck D, McDaniel M, Bollinger F, Vadecha M, Desai S, et al,. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. Ventak CHF Investigators. J Am Coll Cardiol 2000; 36: 824-827.
16. Arya A, Haghjoo M, Dehghani MR, Alasti M, Alizadeh H, Kazemi B, Sadr-Ameli MA,. Effect of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in patients with an implantable cardioverter- defibrillator. Heart Rhythm 2005; 2: 1094-1098. (Pubitemid 41472158)
17. Kashani A, Barold SS,. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 2005; 46: 2183-2192. (Pubitemid 41785483)
18. Bader H, Garrigue S, Lafitte S, Reuter S, Jais P, Haissaguerre M, Bonnet J, et al,. Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol 2004; 43: 248-256. (Pubitemid 38201152)
19. Linde C, Abraham WT, Gold MR, St John SM, Ghio S, Daubert C,. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008; 52: 1834-1843.
20. Aiba T, Hesketh GG, Barth AS, Liu T, Daya S, Chakir K, Dimaano VL, et al,. Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy. Circulation 2009; 119: 1220-1230.
21. Medina-Ravell VA, Lankipalli RS, Yan GX, Antzelevitch C, Medina-Malpica NA, Medina-Malpica OA, Droogan C, et al,. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: Does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation 2003; 107: 740-746. (Pubitemid 36222603)
22. Henrikson CA, Spragg DD, Cheng A, Capps M, Devaughn K, Marine JE, Calkins H, et al,. Evidence for electrical remodeling of the native conduction system with cardiac resynchronization therapy. Pacing Clin Electrophysiol 2007; 30: 591-595. (Pubitemid 46653147)
23. Boriani G, Biffi M, Martignani C, Ziacchi M, Saporito D, Grigioni F, Domenichini G, et al,. Electrocardiographic remodeling during cardiac resynchronization therapy. Int J Cardiol 2006; 108: 165-170. (Pubitemid 43330608)
24. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, et al,. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
25. Bazett H,. An analysis of the time-relations of electrocardiogram. Heart 1920; 7: 353-370.
26. Waggoner AD, De Las FL, Faddis MN, Gleva MJ, Spence KE, Davila-Roman VG,. Left ventricular diastolic filling prior to cardiac resynchronization therapy: Implications for atrioventricular delay programming. Pacing Clin Electrophysiol 2008; 31: 838-844.
27. Kerlan JE, Sawhney NS, Waggoner AD, Chawla MK, Garhwal S, Osborn JL, Faddis MN,. Prospective comparison of echocardiographic atrioventricular delay optimization methods for cardiac resynchronization therapy. Heart Rhythm 2006; 3: 148-154. (Pubitemid 43149986)
28. Sawhney NS, Waggoner AD, Garhwal S, Chawla MK, Osborn J, Faddis MN,. Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy. Heart Rhythm 2004; 1: 562-567. (Pubitemid 39462715)
29. Vogt J, Krahnefeld O, Lamp B, Hansky B, Kirkels H, Minami K, Korfer R, et al,. Electrocardiographic remodeling in patients paced for heart failure. Am J Cardiol 2000; 86: 152K-156K.
30. Stockburger M, Nitardy A, Fateh-Moghadam S, Krebs A, Celebi O, Karhausen T, Dietz R,. Electrical remodeling and cardiac dimensions in patients treated by cardiac resynchronization and heart failure controls. Pacing Clin Electrophysiol 2008; 31: 70-77.
31. Ypenburg C, Van Bommel RJ, Borleffs CJ, Bleeker GB, Boersma E, Schalij MJ, Bax JJ,. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol 2009; 53: 483-490.
32. Aiba T, Hesketh GG, Barth AS, Liu T, Daya S, Chakir K, Dimaano VL, et al,. Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy. Circulation 2009; 119: 1220-1230.
33. Spragg DD, Leclercq C, Loghmani M, Faris OP, Tunin RS, DiSilvestre D, McVeigh ER, et al,. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation 2003; 108: 929-932. (Pubitemid 37048220)
34. Jeyaraj D, Wilson LD, Zhong J, Flask C, Saffitz JE, Deschenes I, Yu X, et al,. Mechanoelectrical feedback as novel mechanism of cardiac electrical remodeling. Circulation 2007; 115: 3145-3155. (Pubitemid 47012229)
35. Vanderheyden M, Mullens W, Delrue L, Goethals M, de BB, Wijns W, Geelen P, et al,. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders. J Am Coll Cardiol 2008; 51: 129-136.
36. Chakir K, Daya SK, Aiba T, Tunin RS, Dimaano VL, Abraham TP, Jaques-Robinson KM, et al,. Mechanisms of enhanced beta-adrenergic reserve from cardiac resynchronization therapy. Circulation 2009; 119: 1231-1240.
37. Barth AS, Aiba T, Halperin V, DiSilvestre D, Chakir K, Colantuoni C, Tunin RS, et al,. Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level. Circ Cardiovasc Genet 2009; 2: 371-378.
38. Rials SJ, Wu Y, Ford N, Pauletto FJ, Abramson SV, Rubin AM, Marinchak RA, et al,. Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart. Circulation 1995; 91: 426-430.
39. Rials SJ, Wu Y, Xu X, Filart RA, Marinchak RA, Kowey PR,. Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation. Circulation 1997; 96: 1330-1336. (Pubitemid 27344240)
40. Peschar M, Vernooy K, Vanagt WY, Reneman RS, Vos MA, Prinzen FW,. Absence of reverse electrical remodeling during regression of volume overload hypertrophy in canine ventricles. Cardiovasc Res 2003; 58: 510-517. (Pubitemid 36694436)
41. van Oosterhout MF, Prinzen FW, Arts T, Schreuder JJ, Vanagt WY, Cleutjens JP, Reneman RS,. Asynchronous electrical activation induces asymmetrical hypertrophy of the left ventricular wall. Circulation 1998; 98: 588-595. (Pubitemid 28371258)
42. van Oosterhout MF, Arts T, Muijtjens AM, Reneman RS, Prinzen FW,. Remodeling by ventricular pacing in hypertrophying dog hearts. Cardiovasc Res 2001; 49: 771-778. (Pubitemid 32178380)
43. Tomlinson DR, Bashir Y, Betts TR, Rajappan K,. Accuracy of manual QRS duration assessment: Its importance in patient selection for cardiac resynchronization and implantable cardioverter defibrillator therapy. Europace 2009; 11: 638-642.